2026 Global: Bioprocess Technology Market-Competitive Review (2032) report
Description
The 2026 Global: Bioprocess Technology Market-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for bioprocess technology market by geography and historical trend. The scope of the report extends to sizing of the bioprocess technology market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Sartorius AG leads the bioprocess technology market as a dominant German provider of equipment for biomanufacturing, including single-use bioreactors, filtration systems, and process analytics essential for upstream and downstream operations. Thermo Fisher Scientific Inc., a U.S.-based giant, excels in comprehensive solutions like cell culture media, fermenters, and purification technologies, bolstered by acquisitions such as Solventum's purification business to enhance downstream capabilities and achieve significant revenue synergies. Lonza Group AG, headquartered in Switzerland, specializes in contract development and manufacturing services (CDMO) for biologics, supporting cell and gene therapies with scalable perfusion cultures and high-density systems driving market growth. Danaher Corporation, through subsidiaries like Cytiva and Pall, commands a broad portfolio spanning bioreactors, chromatography, and filtration, consolidating a $7.5 billion bioprocess unit for end-to-end solutions from cell line development to fill-finish. Merck KGaA (MilliporeSigma) offers critical downstream tools like chromatography resins and viral clearance solutions, holding strong positions in fed-batch and continuous processing amid rising biopharma demand.
GE Healthcare provides advanced imaging-integrated bioprocessing systems, including process monitoring and single-use technologies that align with trends in continuous bioprocessing and personalized medicine. Becton Dickinson and Company (BD) delivers automation and containment solutions for safe handling of biologics, with robust financials supporting expansions in upstream equipment for monoclonal antibodies and vaccines. Eppendorf AG focuses on precision bioreactors and fermenters, enabling high-cell-density cultures pivotal for the 15%+ CAGR in upstream technologies across North America and Asia-Pacific. Bio-Rad Laboratories supplies analytical instruments for protein purification and quality control, integral to downstream dominance that captured over 51% market share in recent years. F. Hoffmann-La Roche Ltd. contributes through integrated platforms for gene editing and cell therapies, leveraging partnerships to accelerate time-to-market in a sector projected to exceed $50 billion by 2029.
These ten companies—Sartorius, Thermo Fisher, Lonza, Danaher, Merck KGaA, GE Healthcare, BD, Eppendorf, Bio-Rad, and Roche—collectively drive the bioprocess market's expansion from $29-38 billion in 2025 to over $140 billion by 2035, fueled by biopharma outsourcing, single-use adoption, and digital twins. Their innovations in perfusion, multi-column chromatography, and analytics address chronic disease demands, with North America leading at 39% share due to regulatory strength and investments like Thermo Fisher's $4.1 billion deals. Strategic mergers, such as Danaher's consolidations, and Asia-Pacific hubs in China and South Korea amplify scalability, positioning them to capture growth in vaccines, enzymes, and advanced therapies amid 14-16% CAGRs.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for bioprocess technology market by geography and historical trend. The scope of the report extends to sizing of the bioprocess technology market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Sartorius AG leads the bioprocess technology market as a dominant German provider of equipment for biomanufacturing, including single-use bioreactors, filtration systems, and process analytics essential for upstream and downstream operations. Thermo Fisher Scientific Inc., a U.S.-based giant, excels in comprehensive solutions like cell culture media, fermenters, and purification technologies, bolstered by acquisitions such as Solventum's purification business to enhance downstream capabilities and achieve significant revenue synergies. Lonza Group AG, headquartered in Switzerland, specializes in contract development and manufacturing services (CDMO) for biologics, supporting cell and gene therapies with scalable perfusion cultures and high-density systems driving market growth. Danaher Corporation, through subsidiaries like Cytiva and Pall, commands a broad portfolio spanning bioreactors, chromatography, and filtration, consolidating a $7.5 billion bioprocess unit for end-to-end solutions from cell line development to fill-finish. Merck KGaA (MilliporeSigma) offers critical downstream tools like chromatography resins and viral clearance solutions, holding strong positions in fed-batch and continuous processing amid rising biopharma demand.
GE Healthcare provides advanced imaging-integrated bioprocessing systems, including process monitoring and single-use technologies that align with trends in continuous bioprocessing and personalized medicine. Becton Dickinson and Company (BD) delivers automation and containment solutions for safe handling of biologics, with robust financials supporting expansions in upstream equipment for monoclonal antibodies and vaccines. Eppendorf AG focuses on precision bioreactors and fermenters, enabling high-cell-density cultures pivotal for the 15%+ CAGR in upstream technologies across North America and Asia-Pacific. Bio-Rad Laboratories supplies analytical instruments for protein purification and quality control, integral to downstream dominance that captured over 51% market share in recent years. F. Hoffmann-La Roche Ltd. contributes through integrated platforms for gene editing and cell therapies, leveraging partnerships to accelerate time-to-market in a sector projected to exceed $50 billion by 2029.
These ten companies—Sartorius, Thermo Fisher, Lonza, Danaher, Merck KGaA, GE Healthcare, BD, Eppendorf, Bio-Rad, and Roche—collectively drive the bioprocess market's expansion from $29-38 billion in 2025 to over $140 billion by 2035, fueled by biopharma outsourcing, single-use adoption, and digital twins. Their innovations in perfusion, multi-column chromatography, and analytics address chronic disease demands, with North America leading at 39% share due to regulatory strength and investments like Thermo Fisher's $4.1 billion deals. Strategic mergers, such as Danaher's consolidations, and Asia-Pacific hubs in China and South Korea amplify scalability, positioning them to capture growth in vaccines, enzymes, and advanced therapies amid 14-16% CAGRs.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.